Skip to main content
Top
Published in: Rheumatology International 8/2023

27-06-2021 | Erythema Nodosum | Case Based Review

Panniculitis as a manifestation of metal-associated autoimmune/inflammatory syndrome induced by adjuvants: a case-based review

Authors: S. G. Radenska-Lopovok, A. O. Kolesnikova, O. N. Egorova, M. V. Severinova, I. D. Musatov

Published in: Rheumatology International | Issue 8/2023

Login to get access

Abstract

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is associated with a hyperergic response of the immune system. The spectrum of clinical changes in ASIA is extensive and difficult to diagnose. Panniculitis is a heterogeneous group of diseases characterized by lesions of the adipose tissue. Panniculitis may become one of the signs of ASIA progress.
To describe the clinical signs and morphological changes in the subcutaneous fat as a manifestation of ASIA, developing after osteosynthesis with metal structures.
In this case-based review, were searched for all articles published in PubMed and Scopus databases until March, 2021 using the following keywords “panniculitis”, “erythema nodosum”, “Weber-Christian Disease”, “idiopathic lobular panniculitis”, “Autoimmune/inflammatory syndrome induced by adjuvants”, “Shoenfeld’s syndrome”, “metal allergy” “metal implants”, “metal hypersensitivity” and reviewed them. Irrelevant items and duplicates were excluded.
We report a case of an adult female patient presenting with a non-healing uninfected surgical wound following implantation of metal osteosynthesis construction and panniculitis developed after surgery. A comprehensive examination of the patient to check for ASIA was conducted. Considering the medical history of exposure to metals, tissue lesions, arthralgia, myalgia, low-grade fever, the disappearance of symptoms on the background of immunosuppressive therapy suggested the diagnosis of ASIA.
Report affords clinicians and pathologists additional insight into the clinical and morphological picture of ASIA-associated panniculitis which, if remain unidentified, may cause severe complications. We recommend the removal of constructions with adjuvant activity in patients with suspected ASIA-associated manifestations.
Literature
21.
go back to reference Stejskal V (2014) Metals as a common trigger of inflammation resulting in non-specific symptoms: diagnosis and treatment. Isr Med Assoc J 16:753–758PubMed Stejskal V (2014) Metals as a common trigger of inflammation resulting in non-specific symptoms: diagnosis and treatment. Isr Med Assoc J 16:753–758PubMed
23.
go back to reference Kagan P, Halpert G, Amital H et al (2020) Autoimmune/inflammatory syndrome induced by adjuvant associated with a metal implant in the mouth; explantation was followed by recovery. Isr Med Assoc J 9:516–517 Kagan P, Halpert G, Amital H et al (2020) Autoimmune/inflammatory syndrome induced by adjuvant associated with a metal implant in the mouth; explantation was followed by recovery. Isr Med Assoc J 9:516–517
27.
go back to reference Caputo V, Rongioletti F (2018) Panniculitis in the setting of dermato/rheumatologic diseases. G Ital Dermatol Venereol 153:194–207PubMed Caputo V, Rongioletti F (2018) Panniculitis in the setting of dermato/rheumatologic diseases. G Ital Dermatol Venereol 153:194–207PubMed
Metadata
Title
Panniculitis as a manifestation of metal-associated autoimmune/inflammatory syndrome induced by adjuvants: a case-based review
Authors
S. G. Radenska-Lopovok
A. O. Kolesnikova
O. N. Egorova
M. V. Severinova
I. D. Musatov
Publication date
27-06-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2023
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04924-1

Other articles of this Issue 8/2023

Rheumatology International 8/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine